ROCKVILLE, Md.--(BUSINESS WIRE)--Emergent BioSolutions Inc. (NYSE: EBS) today announced that its total revenues for 2006 are estimated to be approximately $150 million, based on the company’s preliminary, unaudited results for full year 2006. This represents an increase of approximately 15% over 2005 total revenues of $130.7 million. The company has not finalized its financial statements for 2006, and results are subject to change.
